---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-047087"
form_type: "8-K"
ticker: "JAZZ"
cik: "0001232524"
company_name: "Jazz Pharmaceuticals plc"
filed_at: "2024-02-27T23:59:59+00:00"
generated_at: "2026-06-05T10:47:12.777213+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Jazz Pharmaceuticals appoints Patrick Kennedy to Board; Peter Gray not standing for re-election

## Summary
- Patrick Kennedy appointed as Class I director effective March 1, 2024; term expires at 2024 AGM.
- Kennedy will serve on the Audit Committee; receives standard non-employee director compensation.
- Peter Gray notified the Board he will not stand for re-election at the 2024 Annual Meeting, with no disagreement with the Company.
- Kennedy entered into Jazz's standard indemnification agreement for directors.

## SEC filing metadata
- accession: 0001193125-24-047087
- form_type: 8-K
- ticker: JAZZ
- cik: 0001232524
- company_name: Jazz Pharmaceuticals plc
- filed_at: 2024-02-27T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1232524/000119312524047087/0001193125-24-047087-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1232524/000119312524047087/d783837d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-047087
- JSON: https://secwatch.observer/filing/0001193125-24-047087.json
- Plain text: https://secwatch.observer/filing/0001193125-24-047087.txt

## Key facts
- Executive change
  Peter Gray resigned as Director at Jazz Pharmaceuticals plc.
  - Action: resigned
  - Role: Director
  source text: Peter Gray notified the Board that he will not stand for re-election to the Board, when his term expires, at the 2024 Annual Meeting.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1232524/000119312524047087/0001193125-24-047087-index.htm
- Executive change
  Patrick Kennedy was appointed as Director at Jazz Pharmaceuticals plc.
  - Action: appointed
  - Role: Director
  source text: appointed Patrick Kennedy to the Board, effective as of March 1, 2024, as a Class I director
  evidence_url: https://www.sec.gov/Archives/edgar/data/1232524/000119312524047087/0001193125-24-047087-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.